DOD Publishes Biomanufacturing Strategy and RFI on Biomanufactured Products and Process Capabilities
As part of the National Biotechnology and Biomanufacturing Initiative, the U.S. Department of Defense (DOD) announced in September 2022 an investment of $1.2 billion in bioindustrial domestic ...
The U.S. Department of Defense (DoD) has awarded Phase Three of its Rapid Assured Microelectronics Prototypes – Commercial (RAMP-C) program to Intel Foundry. This means RAMP-C customers can begin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback